103 related articles for article (PubMed ID: 12727936)
1. Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.
Robbins RJ; Robbins AK
J Clin Endocrinol Metab; 2003 May; 88(5):1933-8. PubMed ID: 12727936
[No Abstract] [Full Text] [Related]
2. The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.
Skarulis MC
Rev Endocr Metab Disord; 2000 Apr; 1(3):147-54. PubMed ID: 11705000
[No Abstract] [Full Text] [Related]
3. Differentiated thyroid cancer: an update.
Wang TS; Roman SA; Sosa JA
Curr Opin Oncol; 2011 Jan; 23(1):7-12. PubMed ID: 20861795
[TBL] [Abstract][Full Text] [Related]
4. The role of recombinant thyroid-stimulating hormone (rhTSH) in the detection and management of well-differentiated thyroid carcinoma: a roundtable discussion.
Schlumberger MJ; Incerti C; Pacini F; Reiners C
J Endocrinol Invest; 1999; 22(11 Suppl):35-41. PubMed ID: 10727004
[TBL] [Abstract][Full Text] [Related]
5. [Endocrinology and nuclear medicine aspects of the treatment of thyroid tumours].
Vicek P
Vnitr Lek; 2007; 53(7-8):807-11. PubMed ID: 17915423
[TBL] [Abstract][Full Text] [Related]
6. On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer.
Zanotti-Fregonara P; Hindié E
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2264-6. PubMed ID: 20821206
[No Abstract] [Full Text] [Related]
7. Recombinant human thyrotropin.
Hershman JM
Thyroid; 1999 May; 9(5):419-20. PubMed ID: 10365670
[No Abstract] [Full Text] [Related]
8. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
[TBL] [Abstract][Full Text] [Related]
9. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.
Nielsen VE; Bonnema SJ; Hegedüs L
Clin Endocrinol (Oxf); 2004 Dec; 61(6):655-63. PubMed ID: 15579178
[No Abstract] [Full Text] [Related]
10. Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.
Vargas GE; UY H; Bazan C; Guise TA; Bruder JM
J Clin Endocrinol Metab; 1999 Nov; 84(11):3867-71. PubMed ID: 10566621
[No Abstract] [Full Text] [Related]
11. A new age for recombinant human thyroid-stimulating hormone?
Medvedec M
J Nucl Med; 2009 May; 50(5):832; author reply 832-3. PubMed ID: 19372486
[No Abstract] [Full Text] [Related]
12. Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.
Pacini F; Castagna MG
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1009-21. PubMed ID: 19041828
[TBL] [Abstract][Full Text] [Related]
13. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
Robbins RJ; Pentlow KS
J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
[No Abstract] [Full Text] [Related]
14. Recombinant human TSH: the Argentinean experience.
Pitoia F; Niepomniszcze H
Thyroid; 2009 Jul; 19(7):799. PubMed ID: 19508122
[No Abstract] [Full Text] [Related]
15. [Differentiated thyroid cancer -- 2009].
Konrády A
Orv Hetil; 2011 Jan; 152(5):163-70. PubMed ID: 21247857
[TBL] [Abstract][Full Text] [Related]
16. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.
Schlumberger M; Ricard M; De Pouvourville G; Pacini F
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: why, how and when.
Barbaro D; Boni G
Eur J Surg Oncol; 2007 Jun; 33(5):535-40. PubMed ID: 17337154
[TBL] [Abstract][Full Text] [Related]
19. [Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH].
Rosário PW
Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):338-40. PubMed ID: 22911289
[No Abstract] [Full Text] [Related]
20. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid carcinoma.
McDougall IR
Nucl Med Commun; 1999 Oct; 20(10):871-3. PubMed ID: 10528289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
